Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial
Hoffmann-La Roche
Matthew D Galsky; José Ángel Arranz Arija; Aristotelis Bamias; Ian D Davis; Maria De Santis; Eiji Kikuchi; Xavier Garcia-Del-Muro; Ugo De Giorgi; Marina Mencinger; Kouji Izumi; Stefano Panni; Mahmut Gumus; Mustafa Özgüroğlu; Arash Rezazadeh Kalebasty; Se Hoon Park; Boris Alekseev; Fabio A Schutz; Jian-Ri Li; Dingwei Ye; Nicholas J Vogelzang; Sandrine Bernhard; Darren Tayama; Sanjeev Mariathasan; Almut Mecke; AnnChristine Thåström; Enrique Grande; IMvigor130 Study Group